Cooper Companies Stock Drops After Inventory Reduction Disclosures
The Cooper Companies' stock price fell sharply after the company reported third-quarter financial results that revealed U.S. channel inventory destocking.
Shares of The Cooper Companies, Inc. (NASDAQ: COO) declined 14.6%, or approximately $9.31, following the company's third-quarter 2026 financial report released on Friday. The stock's drop erased more than $1.7 billion from the company's market capitalization.
The revelations regarding U.S. channel inventory reductions have prompted a legal investigation. Shareholder rights firm Hagens Berman has initiated an inquiry to determine if The Cooper Companies provided sufficient transparency to investors about its sales practices and if the company may have violated securities laws.
CooperVision, the largest segment of The Cooper Companies and accounting for approximately 67% of total consolidated sales, reported significant challenges. CEO Albert White III stated that the entire reduction in CooperVision's revenue guidance was attributed to channel inventory destocking. Analysts have expressed concerns about the reasons for the destocking, questioning whether past efforts to "prop up numbers" led to excess inventory.
The Cooper Companies, a global medical device company specializing in contact lenses and women's healthcare products, saw its stock reach a 52-week low. Several analysts have reportedly downgraded their ratings and price targets for the company. The law firm is encouraging Cooper investors who have suffered substantial losses to submit their information for the investigation.